Charles Schwab’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-115,237
| Closed | -$113K | – | 3558 |
|
|
2025
Q1 | $113K | Sell |
115,237
-14,524
| -11% | -$14.2K | ﹤0.01% | 3330 |
|
|
2024
Q4 | $202K | Hold |
129,761
| – | – | ﹤0.01% | 3326 |
|
|
2024
Q3 | $476K | Hold |
129,761
| – | – | ﹤0.01% | 3173 |
|
|
2024
Q2 | $430K | Buy |
129,761
+115,237
| +793% | +$381K | ﹤0.01% | 3258 |
|
|
2024
Q1 | $61.9K | Buy |
+14,524
| New | +$61.9K | ﹤0.01% | 3347 |
|
|
2023
Q2 | – | Sell |
-17,739
| Closed | -$71.1K | – | 3666 |
|
|
2023
Q1 | $71.1K | Hold |
17,739
| – | – | ﹤0.01% | 3292 |
|
|
2022
Q4 | $23.8K | Hold |
17,739
| – | – | ﹤0.01% | 3479 |
|
|
2022
Q3 | $35K | Buy |
+17,739
| New | +$35K | ﹤0.01% | 3409 |
|
|
2022
Q2 | – | Sell |
-23,094
| Closed | -$94K | – | 3624 |
|
|
2022
Q1 | $94K | Hold |
23,094
| – | – | ﹤0.01% | 3421 |
|
|
2021
Q4 | $254K | Buy |
+23,094
| New | +$254K | ﹤0.01% | 3316 |
|